These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26075502)

  • 1. Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis.
    Radtke MA; Mrowietz U; Feuerhahn J; Härter M; von Kiedrowski R; Nast A; Reich K; Strömer K; Wohlrab J; Augustin M
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):674-90. PubMed ID: 26075502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.
    Nast A; Boehncke WH; Mrowietz U; Ockenfels HM; Philipp S; Reich K; Rosenbach T; Sammain A; Schlaeger M; Sebastian M; Sterry W; Streit V; Augustin M; Erdmann R; Klaus J; Koza J; Muller S; Orzechowski HD; Rosumeck S; Schmid-Ott G; Weberschock T; Rzany B; ;
    J Dtsch Dermatol Ges; 2012 Mar; 10 Suppl 2():S1-95. PubMed ID: 22386073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris.
    Nast A; Kopp IB; Augustin M; Banditt KB; Boehncke WH; Follmann M; Friedrich M; Huber M; Kahl C; Klaus J; Koza J; Kreiselmaier I; Mohr J; Mrowietz U; Ockenfels HM; Orzechowski HD; Prinz J; Reich K; Rosenbach T; Rosumeck S; Schlaeger M; Schmid-Ott G; Sebastian M; Streit V; Weberschock T; Rzany B; ;
    J Dtsch Dermatol Ges; 2007 Jul; 5 Suppl 3():1-119. PubMed ID: 17615051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position statement for the management of comorbidities in psoriasis.
    Dauden E; Blasco AJ; Bonanad C; Botella R; Carrascosa JM; González-Parra E; Jodar E; Joven B; Lázaro P; Olveira A; Quintero J; Rivera R
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2058-2073. PubMed ID: 29992631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm.
    Linder D; Altomare G; Amato S; Amerio P; Balato N; Campanati A; Conti A; Gisondi P; Prignano F; Saraceno R; Piaserico S
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1310-7. PubMed ID: 25370415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Psoriasis Comorbidity Screening Guidelines.
    Osier E; Wang AS; Tollefson MM; Cordoro KM; Daniels SR; Eichenfield A; Gelfand JM; Gottlieb AB; Kimball AB; Lebwohl M; Mehta NN; Paller AS; Schwimmer JB; Styne DM; Van Voorhees AS; Tom WL; Eichenfield LF
    JAMA Dermatol; 2017 Jul; 153(7):698-704. PubMed ID: 28514463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing best practice in psoriasis: a Nordic expert group consensus.
    Kragballe K; Gniadecki R; Mørk NJ; Rantanen T; Ståhle M
    Acta Derm Venereol; 2014 Sep; 94(5):547-52. PubMed ID: 24549301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implementation of the S3-guidelines for systemic and UV therapy of moderate to severe psoriasis vulgaris by an algorithm].
    Weisenseel P; Kuznetsov AV; Prinz JC
    J Dtsch Dermatol Ges; 2007 Aug; 5(8):683-8. PubMed ID: 17659043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
    Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
    J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and cardiovascular screening rates in the United States.
    Alamdari HS; Gustafson CJ; Davis SA; Huang W; Feldman SR
    J Drugs Dermatol; 2013 Jan; 12(1):e14-9. PubMed ID: 23377342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [S3-guidelines for the treatment of psoriasis vulgaris--methods report].
    Nast A; Rosumeck S; Sammain A; Erdmann R; Sporbeck B; Rzany B
    J Dtsch Dermatol Ges; 2011 Jun; 9 Suppl 2():e64-84. PubMed ID: 21627772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current guidelines in dermatology : A selection of clinically relevant recommendations].
    Nast A; Rosumeck S; Erdmann R; Dressler C; Werner RN
    Hautarzt; 2016 May; 67(5):391-6. PubMed ID: 27052528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current dermatology guidelines in Germany-selected recommendations from 2021 and 2022].
    Pennitz A; Breitbart E; Clanner-Engelshofen BM; Dickel H; Eisert L; Nenoff P; Paasch U; Schmidt E; Ständer S; Zidane M; Nast A
    Dermatologie (Heidelb); 2023 Jul; 74(7):527-534. PubMed ID: 37266595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis.
    Prignano F; Tripo L; Amato L; Bagnoni G; Bartoli L; Battistini S; Bellini M; Brandini L; Caproni M; Cardinali C; Castelli A; Cecchi R; Cervadoro G; Dini V; Fimiani M; Eberle O; Fabbri P; Lo Scocco G; Martini P; Marsili F; Mazzatenta C; Niccoli MC; Peccianti C; Pellegrino M; Romanelli M; Sirna R; Taviti F; Volpi V; Pimpinelli N
    G Ital Dermatol Venereol; 2017 Apr; 152(2):99-108. PubMed ID: 25588061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improved quality of healthcare through dermatological health services research : Effects of structured programs on psoriasis and skin cancer].
    Gehoff M; Augustin M
    Hautarzt; 2018 Oct; 69(10):801-808. PubMed ID: 30116831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification.
    Follmann M; Schadendorf D; Kochs C; Buchberger B; Winter A; Wesselmann S
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):139-47. PubMed ID: 24238575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Psoriasis Comorbidities.
    Kittler NW; Cordoro KM
    Skin Therapy Lett; 2020 Nov; 25(5):1-6. PubMed ID: 33196156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]].
    Luger T; Reusch M; Reich K; Augustin M; Sterry W
    J Dtsch Dermatol Ges; 2009 Apr; 7(4):291-2. PubMed ID: 19500192
    [No Abstract]   [Full Text] [Related]  

  • 19. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
    Sterry W; Strober BE; Menter A;
    Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study.
    Jacobi A; Kupke C; Behzad M; Hertl M
    Int J Dermatol; 2013 Sep; 52(9):1081-7. PubMed ID: 23432542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.